Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Gastric Cancer

  Free Subscription


Articles published in Br J Cancer

Retrieve available abstracts of 45 articles:
HTML format



Single Articles


    March 2024
  1. SUH YS, Lee J, George J, Seol D, et al
    RNA expression of 6 genes from metastatic mucosal gastric cancer serves as the global prognostic marker for gastric cancer with functional validation.
    Br J Cancer. 2024 Mar 11. doi: 10.1038/s41416-024-02642.
    PubMed     Abstract available


    February 2024
  2. SAITO T, Kurokawa Y, Fujitani K, Kawabata R, et al
    Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
    Br J Cancer. 2024 Feb 7. doi: 10.1038/s41416-023-02540.
    PubMed     Abstract available


  3. CECCHINI M, Cleary JM, Shyr Y, Chao J, et al
    NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and gastroesophageal junction adenocarcinoma.
    Br J Cancer. 2024;130:476-482.
    PubMed     Abstract available


  4. GROSSER B, Emmerson J, Reitsam NG, Cunningham D, et al
    Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.
    Br J Cancer. 2024;130:457-466.
    PubMed     Abstract available


    January 2024
  5. WANG J, Sun N, Kunzke T, Shen J, et al
    Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer.
    Br J Cancer. 2024 Jan 24. doi: 10.1038/s41416-023-02559.
    PubMed     Abstract available


  6. CAI F, Yang X, Ma G, Wang P, et al
    EGLN3 attenuates gastric cancer cell malignant characteristics by inhibiting JMJD8/NF-kappaB signalling activation independent of hydroxylase activity.
    Br J Cancer. 2024 Jan 6. doi: 10.1038/s41416-023-02546.
    PubMed     Abstract available


    December 2023
  7. KAMIYA H, Komatsu S, Takashima Y, Ishida R, et al
    Low blood level of tumour suppressor miR-5193 as a target of immunotherapy to PD-L1 in gastric cancer.
    Br J Cancer. 2023 Dec 26. doi: 10.1038/s41416-023-02532.
    PubMed     Abstract available


    November 2023
  8. ALLAN Z, Witts S, Tie J, Tebbutt N, et al
    The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review.
    Br J Cancer. 2023;129:1717-1726.
    PubMed     Abstract available


    August 2023
  9. CHEN T, Li D, Wang Y, Shen X, et al
    Loss of NDUFS1 promotes gastric cancer progression by activating the mitochondrial ROS-HIF1alpha-FBLN5 signaling pathway.
    Br J Cancer. 2023 Aug 29. doi: 10.1038/s41416-023-02409.
    PubMed     Abstract available


  10. ANDO K, Nakamura Y, Kitao H, Shimokawa M, et al
    Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
    Br J Cancer. 2023 Aug 2. doi: 10.1038/s41416-023-02378.
    PubMed     Abstract available


    July 2023
  11. LIU X, Lv K, Wang J, Lin C, et al
    C-type lectin receptor Dectin-1 blockade on tumour-associated macrophages improves anti-PD-1 efficacy in gastric cancer.
    Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02336.
    PubMed     Abstract available


  12. LEE JE, Kim KT, Shin SJ, Cheong JH, et al
    Genomic and evolutionary characteristics of metastatic gastric cancer by routes.
    Br J Cancer. 2023 Jul 8. doi: 10.1038/s41416-023-02338.
    PubMed     Abstract available


    June 2023
  13. DONG X, Fan J, Xie W, Wu X, et al
    Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer.
    Br J Cancer. 2023 Jun 29. doi: 10.1038/s41416-023-02319.
    PubMed     Abstract available


    April 2023
  14. LIU DHW, Kim YW, Sefcovicova N, Laye JP, et al
    Tumour infiltrating lymphocytes and survival after adjuvant chemotherapy in patients with gastric cancer: post-hoc analysis of the CLASSIC trial.
    Br J Cancer. 2023 Apr 7. doi: 10.1038/s41416-023-02257.
    PubMed     Abstract available


  15. LAAKSONEN MA, Li S, Canfell K, MacInnis RJ, et al
    The future burden of oesophageal and stomach cancers attributable to modifiable behaviours in Australia: a pooled cohort study.
    Br J Cancer. 2023;128:1052-1069.
    PubMed     Abstract available


    February 2023
  16. STARLING N, Cunningham D
    Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer: S Pyrhonen, T Kuitunen, P Nyandoto & M Kouri.
    Br J Cancer. 2023 Feb 16. doi: 10.1038/s41416-023-02146.
    PubMed     Abstract available


    January 2023
  17. NI T, Chu Z, Tao L, Zhao Y, et al
    PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.
    Br J Cancer. 2023 Jan 12. doi: 10.1038/s41416-022-02118.
    PubMed     Abstract available


  18. OKUNO K, Watanabe S, Roy S, Kanda M, et al
    A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
    Br J Cancer. 2023 Jan 11. doi: 10.1038/s41416-022-02138.
    PubMed     Abstract available


    November 2022
  19. KOCK AM BRINK M, Dunst LS, Behrens HM, Kruger S, et al
    Intratumoral heterogeneity affects tumor regression and Ki67 proliferation index in perioperatively treated gastric carcinoma.
    Br J Cancer. 2022 Nov 8. pii: 10.1038/s41416-022-02047.
    PubMed     Abstract available


    August 2022
  20. YU K, Gu Y, Zhang P, Fang H, et al
    Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer.
    Br J Cancer. 2022 Aug 24. pii: 10.1038/s41416-022-01939.
    PubMed     Abstract available


  21. CUI K, Yao S, Liu B, Sun S, et al
    A novel high-risk subpopulation identified by CTSL and ZBTB7B in gastric cancer.
    Br J Cancer. 2022 Aug 8. pii: 10.1038/s41416-022-01936.
    PubMed     Abstract available


    June 2022
  22. RABBANI S, Santoni G, Lagergren J, Xie SH, et al
    Use of anti-androgenic 5alpha-reductase inhibitors and risk of oesophageal and gastric cancer by histological type and anatomical sub-site.
    Br J Cancer. 2022 Jun 17. pii: 10.1038/s41416-022-01872.
    PubMed     Abstract available


    May 2022
  23. YAO X, He Z, Qin C, Zhang P, et al
    Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisation.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01834.
    PubMed     Abstract available


  24. ZANG WJ, Hu YL, Qian CY, Feng Y, et al
    HDAC4 promotes the growth and metastasis of gastric cancer via autophagic degradation of MEKK3.
    Br J Cancer. 2022 May 30. pii: 10.1038/s41416-022-01805.
    PubMed     Abstract available


  25. ALICANDRO G, Bertuccio P, Collatuzzo G, Pelucchi C, et al
    The mediating role of combined lifestyle factors on the relationship between education and gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 May 27. pii: 10.1038/s41416-022-01857.
    PubMed     Abstract available


  26. MARTIMIANAKI G, Alicandro G, Pelucchi C, Bonzi R, et al
    Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium.
    Br J Cancer. 2022 May 24. pii: 10.1038/s41416-022-01856.
    PubMed     Abstract available


    February 2022
  27. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Correction: Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01761.
    PubMed    


  28. DALMARTELLO M, Turati F, Zhang ZF, Lunet N, et al
    Allium vegetables intake and the risk of gastric cancer in the Stomach cancer Pooling (StoP) Project.
    Br J Cancer. 2022 Feb 24. pii: 10.1038/s41416-022-01750.
    PubMed     Abstract available


  29. LI Y, Liu C, Zhang X, Huang X, et al
    CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt/beta-catenin signalling pathway.
    Br J Cancer. 2022 Feb 22. pii: 10.1038/s41416-022-01747.
    PubMed     Abstract available


    January 2022
  30. ZHENG J, Gao Y, Xie SH, Santoni G, et al
    Haemoglobin A1c and serum glucose levels and risk of gastric cancer: a systematic review and meta-analysis.
    Br J Cancer. 2022 Jan 13. pii: 10.1038/s41416-021-01693.
    PubMed     Abstract available


    December 2021
  31. ADIB E, El Zarif T, Nassar AH, Akl EW, et al
    CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
    Br J Cancer. 2021 Dec 23. pii: 10.1038/s41416-021-01673.
    PubMed     Abstract available


    November 2021
  32. CHEN K, Gu Y, Cao Y, Fang H, et al
    TIM3(+) cells in gastric cancer: clinical correlates and association with immune context.
    Br J Cancer. 2021 Nov 1. pii: 10.1038/s41416-021-01607.
    PubMed     Abstract available


    October 2021
  33. SHIMURA T, Kandimalla R, Okugawa Y, Ohi M, et al
    Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer.
    Br J Cancer. 2021 Oct 21. pii: 10.1038/s41416-021-01581.
    PubMed     Abstract available


  34. KOHLRUSS M, Krenauer M, Grosser B, Pfarr N, et al
    Diverse 'just-right' levels of chromosomal instability and their clinical implications in neoadjuvant treated gastric cancer.
    Br J Cancer. 2021 Oct 20. pii: 10.1038/s41416-021-01587.
    PubMed     Abstract available


  35. BAXTER MA, Middleton F, Cagney HP, Petty RD, et al
    Resistance to immune checkpoint inhibitors in advanced gastro-oesophageal cancers.
    Br J Cancer. 2021;125:1068-1079.
    PubMed     Abstract available


    July 2021
  36. ZHENG J, Santoni G, Xie SH, Lagergren J, et al
    Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study.
    Br J Cancer. 2021;125:277-283.
    PubMed     Abstract available


    June 2021
  37. LEE IS, Ahn J, Kim K, Okugawa Y, et al
    A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer.
    Br J Cancer. 2021 Jun 23. pii: 10.1038/s41416-021-01461.
    PubMed     Abstract available


    April 2021
  38. TANAKA H, Kanda M, Miwa T, Umeda S, et al
    G-protein subunit gamma-4 expression has potential for detection, prediction and therapeutic targeting in liver metastasis of gastric cancer.
    Br J Cancer. 2021 Apr 14. pii: 10.1038/s41416-021-01366.
    PubMed     Abstract available


    March 2021
  39. TAKASHIMA T, Taniyama D, Sakamoto N, Yasumoto M, et al
    Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.
    Br J Cancer. 2021 Mar 30. pii: 10.1038/s41416-021-01364.
    PubMed     Abstract available


  40. LI Z, Wu X, Gao X, Shan F, et al
    Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma.
    Br J Cancer. 2021;124:942-950.
    PubMed     Abstract available


    February 2021
  41. MIWA T, Kanda M, Shimizu D, Umeda S, et al
    Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53-Bcl-2 intrinsic apoptosis pathway.
    Br J Cancer. 2021 Feb 3. pii: 10.1038/s41416-021-01271.
    PubMed     Abstract available


    October 2020
  42. SAITO R, Shoda K, Maruyama S, Yamamoto A, et al
    Platelets enhance malignant behaviours of gastric cancer cells via direct contacts.
    Br J Cancer. 2020 Oct 28. pii: 10.1038/s41416-020-01134.
    PubMed     Abstract available


  43. YAMASHITA K, Iwatsuki M, Yasuda-Yoshihara N, Morinaga T, et al
    Trastuzumab upregulates programmed death ligand-1 expression through interaction with NK cells in gastric cancer.
    Br J Cancer. 2020 Oct 26. pii: 10.1038/s41416-020-01138.
    PubMed     Abstract available


  44. OPENSHAW MR, Mohamed AA, Ottolini B, Fernandez-Garcia D, et al
    Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
    Br J Cancer. 2020;123:1271-1279.
    PubMed     Abstract available


    September 2020
  45. ZHAO J, Fu X, Chen H, Min L, et al
    G3BP1 interacts with YWHAZ to regulate chemoresistance and predict adjuvant chemotherapy benefit in gastric cancer.
    Br J Cancer. 2020 Sep 29. pii: 10.1038/s41416-020-01067.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.